Immediate Impact
1 by Nobel laureates 52 standout
Citing Papers
Mechanisms and functions of protein S-acylation
2024 Standout
Neutrophils in Cancer immunotherapy: friends or foes?
2024 Standout
Works of Carrie Cartwright being referenced
Phase 1 trial evaluating TTI-101, a first-in-class, orally bioavailable, small molecule, inhibitor of STAT3, in patients with advanced solid tumors.
2023
Preclinical Development and First-in-Human Study of KA2507, a Selective and Potent Inhibitor of Histone Deacetylase 6, for Patients with Refractory Solid Tumors
2021
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Carrie Cartwright | 435 | 181 | 235 | 24 | 818 | |
| Judith R. Fay | 473 | 180 | 192 | 14 | 874 | |
| Giulia Piazzi | 458 | 167 | 348 | 28 | 855 | |
| Donatella Vizza | 441 | 137 | 185 | 30 | 922 | |
| Maureen O. Ripple | 541 | 104 | 130 | 21 | 880 | |
| Lokesh Dalasanur Nagaprashantha | 572 | 161 | 113 | 23 | 934 | |
| Sen Lian | 475 | 146 | 177 | 27 | 897 | |
| Sumit J. Shah | 439 | 130 | 138 | 21 | 851 | |
| Jin Zhao | 478 | 346 | 89 | 31 | 969 | |
| Satya S. Pathi | 714 | 147 | 353 | 21 | 962 | |
| David G. Thomassen | 317 | 136 | 155 | 36 | 921 |
All Works
Loading papers...